Telaprevir (VX-950)

Telaprevir(VX-950)は、C型肝炎ウイルス(HCV)NS3-4Aセリン・プロテアーゼ阻害剤で、IC50 が0.35 μMになる。

価格 在庫  
USD 214 あり
USD 340 あり
USD 970 あり
電話番号: + 81

Telaprevir (VX-950) 化学構造
分子量: 679.85





  • Compare HCV Protease Inhibitors
    HCV Protease製品生物活性の比較
  • 研究分野



製品説明 Telaprevir(VX-950)は、C型肝炎ウイルス(HCV)NS3-4Aセリン・プロテアーゼ阻害剤で、IC50 が0.35 μMになる。
ターゲット HCV NS3-4A serine protease
IC50 0.35 μM [1]
In vitro試験 Telaprevir inhibits the hepatitis C virus NS3-4A serine protease, leading to the block of viral polyprotein processing and subsequently decrease of viral RNA replication, total HCV RNA levels and protein levels in the Con1 (genotype 1b) subgenomic HCV replicon cells in a time- and dose-dependent manner. Telaprevir displays a significant time-dependent increase in inhibitory effect on the replication of HCV RNA with IC50 values of 0.574 μM, 0.488 μM, 0.210 μM and 0.139 μM for 24, 48, 72 and 120 hours incubation, respectively. Telaprevir displays an average IC50 of 0.354 μM and an average IC90 of 0.830 μM, respectively, from three independent experiments using the 48 hours incubation. Telaprevir has no significant cytotoxicity to HCV replicon cells, parental Huh-7 and HepG2 cells after 48 hours incubation. Telaprevir (17.5 μM) completely eradicates HCV RNA from replicon cells after 13 days incubation without rebound after Telaprevir is withdrawn. Telaprevir displays an additive to moderate synergistic effect on reduction of HCV RNA replication and suppression of resistance mutations without significant increase in cytotoxicity when in combination with IFN-α, compared to treatment with each agent alone. [1]
In vivo試験 Oral administration of Telaprevir reduces HCV protease-dependent cleavage and subsequent secretion of SEAP from the liver into the blood in the mice model to 18.7% and 18.4% at dosage of 10 and 25 mg/kg, respectively. [2] Administration of Telaprevir at 200 mg/kg for 1 week results in a 1.9 log reduction of HCV RNA in genotype 1b HCV-infected human hepatocyte chimeric mice, and when treatment in combination with MK-0608 (50 mg/kg) for 4 weeks, viruses are eliminated from mice. [3]
臨床試験 Currently in Phase III clinical trials in patients with Hepatitis C.
特集 Telaprevir is a covalent, reversible inhibitor of the NS3-4A protease (unlike BILN 2061which is a noncovalent inhibitor), with a slow-binding and slow-dissociation mechanism.

プロトコル (参考用のみ)

キナーゼアッセイ: [1]

Determination of anti-HCV activity Stable Huh-7 cells containing the self-replicating, subgenomic HCV replicon, which is identical in sequence to the I377neo/NS3-3'/wt replicon are used for anti-HCV assays. Replicon cells are incubated at 37 °C for the indicated period of time with Telaprevir serially diluted in DMEM plus 2% FBS and 0.5% dimethyl sulfoxide (DMSO). Total cellular RNA is extracted using an RNeasy-96 kit, and the copy number of HCV RNA is determined using a quantitative RTPCR (QRT-PCR) assay for the assessment of 50% inhibitory concentration (IC50

細胞アッセイ: [1]

細胞株 Huh-7, HepG2, and peripheral blood mononuclear cells (PBMC)
濃度 Dissolved in DMSO, final concentration ~1 mM
反応時間 48 hours
実験の流れ Cells are incubated with various concentrations of Telaprevir for 48 hours. Cell viability is determined by using a tetrazolium (MTS)-based cell viability assay.

動物実験: [2]

動物モデル SCID mice injected with recombinant adenovirus (Ad-WT-HCVpro-SEAP or Ad-MT-HCVpro-SEAP)
製剤 Formulated in polyvinylpyrrolidone (PVP) K-30 plus 2% sodium lauryl sulfate
投薬量 ~300 mg/kg
投与方法 Oral gavage

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDogMonkeyBaboon
Weight (kg)
Body Surface Area (m2)0.0070.0250.
Km factor361285201220
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)



Download Telaprevir (VX-950) SDF
分子量 679.85


CAS No. 402957-28-2
保管 3年-20℃
2年-80℃in solvent
別名 LY-570310, MP-424
溶解度 (25°C) * In vitro DMSO 136 mg/mL (200.04 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 (1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl)-octahydrocyclopenta[c]pyrrole-1-carboxamide

文献中の引用 (10)



電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related HCVプロテアーゼ 阻害剤

  • Ledipasvir (GS5885)

    Ledipasvir(GS5885)は1種のHCV NS5Aポリメラーゼ(polymerase)阻害剤で、C型肝炎ウイルス感染の治療に使用します。

  • Calpeptin

    Calpeptinは1種の有効的で、細胞浸透性のカルパイン( calpain)阻害剤で、カルパインI(豚赤血球)、カルパインII (豚腎臓)、パパイン(Papain)とカルパインI(人血小板)に対するID50値は52 nM、34 nM、138 nMと40 nMそれぞれに分かれます。

  • Marimastat (BB-2516)

    Marimastat (BB-2516)は1種の広範囲に使用されるマトリックスメタロプロテアーゼ(MMP)阻害剤で、MMP-9、MMP-1、MMP-2、MMP-14とMMP-7に作用する IC50値は3 nM、5 nM、6 nM、9 nMと13 nMそれぞれに分かれます。臨床3期。

  • Danoprevir (ITMN-191)

    Danoprevir (ITMN-191)はB型肝炎ウイルス(HCV)のNS3/4Aプロティナーゼの模擬阻害剤、 IC50 が 0.2-3.5 nM.

    Features:A peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV).

  • Daclatasvir (BMS-790052)

    Daclatasvir (BMS-790052) は一流、高選択性の C型肝炎ウイルス(HCV)阻害剤、EC50 が9–50 pM.

    Features:First-in-class, highly selective inhibitor of hepatitis C virus (HCV) NS5A with picomolar EC50 values.

  • VX-222 (VCH-222, Lomibuvir)

    VX-222 (VCH-222, Lomibuvir)は新型有効と選択の非核苷ポリメラーゼ阻害剤、C型肝炎ウイルス(HCV)RNA依存のRNAポリメラーゼを抑制する時、 IC50 が 0.94-1.2 μMになる.

    Features:A novel, potent and selective inhibitor of non-nucleoside polymerase, specifically the HCV RNA-dependent RNA polymerase.

  • MG-132


  • Bortezomib (PS-341)

    Bortezomib (PS-341)は、強力なプロテアソーム阻害剤で、Kiが0.6nMです。

  • Carfilzomib (PR-171)

    Carfilzomib (PR-171) is a proteasome inhibitor with IC50 less than 5 nM.


Tags: Telaprevir (VX-950)を買う | Telaprevir (VX-950)供給者 | Telaprevir (VX-950)を購入する | Telaprevir (VX-950)費用 | Telaprevir (VX-950)生産者 | オーダーTelaprevir (VX-950) | Telaprevir (VX-950)代理店
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID